undamentalytics Newsletter

Avita Medical, Inc. cash flow statement

In fiscal 2025, Avita Medical, Inc.'s operations generated −$31.2m of cash; it spent $1.0m on capital projects, leaving free cash flow of −$32.2m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Avita Medical, Inc.: cash flow statement, annual
Fiscal year2018Jun 20182019Jun 20192020Jun 20202021Jun 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−13−19−23−26−19−38−49−31−24
Depreciation and amortisation000111122
Stock-based pay121667813107
Capital spending011101910
Free cash flow−13−20−23−27−20−39−58−32−25
Free cash flow after stock pay−15−22−40−32−27−48−72−42−32
Shares issued23328269———15—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ELMD vs RCELPDEX vs RCELRCEL vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Avita Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Avita Medical, Inc.